Yellow fever: regional surge, changes in requirements and access to the vaccine

  • Colombia reports more than 100 cases and maintains active surveillance; PAHO confirms regional increase.
  • Costa Rica is promoting campaigns for travelers to Colombia and preparing the CCSS (Certificate of Social Security) to administer the vaccine.
  • Ecuador moves from requiring to recommending vaccination certificates based on risk and strengthens immunization in the Amazon.
  • Argentina limits free vaccines to endemic areas, and prices in pharmacies skyrocket.

Yellow fever prevention

Yellow fever is once again in the spotlight of health authorities in Latin America for a Increase in cases and adjustments to travel requirementsSeveral countries have implemented vaccination measures, risk screening, and information campaigns, while also fine-tuning epidemiological surveillance to address possible spread of the virus.

With the vaccine as key tool and collaboration between health ministries, international organizations, and healthcare services, the goal is to reduce mortality and break chains of transmission. Authorities insist on checking current requirements before traveling and on getting vaccinated well in advance to ensure the certificate's validity.

Epidemiological situation in Colombia and the region

Yellow fever situation in the region

The Colombian Ministry of Health notified 109 cases and 44 deaths due to yellow fever with a preliminary cut-off at 17:00 p.m. on August 31, with the greatest impact in departments in the Andean and Amazonian regions. The distribution includes territories such as Tolima, Huila, Cauca, Nariño, Putumayo, Caldas, Guaviare, Meta, Vaupés and Caquetá, and may vary after further analysis due to continuous monitoring.

In the regional context, the Pan American Health Organization reported that between January and May were confirmed 235 cases and 96 deaths yellow fever in Latin America, with Brazil and Colombia among the most affected countries. The agency warns of a upward trend which requires strengthening vaccination coverage and vector control.

For those who travel between countries, authorities recommend consulting official sources (WHO/PAHO and Ministries of Health) on requirements of an international certificate. The epidemiological situation is dynamic, and lists of countries or risk zones can be updated quickly.

Costa Rica: Campaigns for travelers and preparations at the CCSS

The National Commission on Vaccination and Epidemiology approved that the CCSS may vaccinate travelers against yellow fever within a special schedule, pending the issuance of guidelines by the Pharmacotherapy Committee. It will not be incorporated into the basic calendar, but specific strategies focused on travel to high-risk countries in South America and Africa.

While this step is being carried out, the Ministry of Health maintains extraordinary daysA new campaign is being held on Thursday 4th and Friday 5th September at the National Stadium (8:00 to 12:00), with 600 appointments in total. It is aimed at those traveling to Colombia in September or October and who purchased their ticket before August 15; appointment requests are available on Monday, September 1 at 14:00 p.m. www.misteriodesalud.go.cr/citas/citas.html.

In view of border control, the authorities remind that the certificate can be demanded to travelers from areas with active outbreaks, such as Colombia, so it is advisable to confirm the requirement before flying to avoid setbacks when boarding or entering the country.

Ecuador moves from mandatory to recommended

Ecuador modified its policy and stop demanding The yellow fever vaccination certificate is required for people entering from Colombia, Peru, Bolivia, and Brazil. Vaccination remains recommended, especially for those traveling to jungle areas or difficult to access.

The decision comes after a risk assessment and progress in the national campaign: they have been applied 523.953 doses in the country, of which 157.874 correspond to Amazonian provinces (Sucumbíos, Napo, Orellana, Pastaza, Morona Santiago and Zamora Chinchipe). The Ministry of Public Health maintains surveillance and vector control, with moderate risk on the Coast and periodic reviews according to evolution.


Although the obligation is eliminated, co-responsibility is encouraged: get vaccinated at least 10 days before traveling to risk areas protects the traveler and reduces cross-border spread. The measures may harden if the epidemiological scenario requires it.

Argentina: Access, Price, and Risk-Based Approach

In Argentina, the vaccine stopped being offered free nationwide (beyond the target population in endemic areas) and began to be marketed in pharmacies. In Rosario, the reported cost is around 214.000 pesos, and is not covered by social security or prepaid health plans.

Free access is maintained for at-risk populations in Misiones, Corrientes, Formosa and selected departments of Salta, Jujuy and Chaco. Local authorities expect Greater demand as the season progresses and they recommend planning ahead.

The offer is limited, with a single laboratory producing the biological. It is recalled that immunization acquires validity 10 days after application, a key requirement for travelers who must present the certificate.

The disease: transmission, symptoms and prevention

Yellow fever is a acute viral illness of potential hemorrhagic character, transmitted by mosquitoes of the genus Aedes, the same vector involved in dengue, Zika virus in pregnancy and chikungunya. Vaccination and vector control are essential pillars.

The incubation period is usually 3 to 6 daysThe acute phase presents with fever and myalgia, similar to symptoms of dengue in children, and in severe cases a toxic phase may appear with jaundice, bleeding and multisystem involvement. Severe forms present a high lethality in the short term if not addressed immediately.

They do not exist specific antivirals against yellow fever. Management focuses on clinical support, hydration and monitoring, avoiding self-medication (especially with anti-inflammatory) and substances that may complicate the evolution.

Preventive measures include eliminate breeding grounds from mosquitoes, clean and cover water tanks weekly, use repellent frequently wear clothing that covers the skin and report any findings of dead wildlife to health authorities.

In outbreak or high-risk scenarios, the health strategy prioritizes vaccination of residents in endemic and traveler areas. Depending on the jurisdiction, administration is contemplated from 9 months old already adults with indication, always taking into account availability and current technical criteria.

Facing a season with regional reboundPolicies are being adjusted country by country: Colombia is strengthening surveillance, Costa Rica is organizing campaigns for travelers, Ecuador is relaxing the certificate according to risk, and Argentina is redefining access to the vaccine; in all cases, plan immunization, confirming requirements and maintaining personal prevention make the difference.

The Dengue
Related article:
Dengue in Spain, should we worry?